Temple Faculty Physicians is experiencing technical issues with phone lines. If you are experiencing an emergency, please visit your nearest emergency room. If you would like to schedule an appointment with your provider or have general questions or requests, please contact us by using myTempleHealth.

myTempleHealth
800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH

Media Outlet Highlights New Study Led by Researchers from the Fels Cancer Institute for Personalized Medicine and Fox Chase Cancer Center on Leukemia Gene Mutations and PARP Inhibitors

View All News

Tomasz Skorski, MD, PhD, DSc, Director of the Fels Cancer Institute for Personalized Medicine at the Lewis Katz School of Medicine at Temple University, is the senior author on a recent study published in the journal Cancer Research which identified specific leukemia gene mutations and the mechanisms by which they regulate DNA repair and respond to PARP inhibitors. The research was led by scientists from the Fels Cancer Institute for Personalized Medicine and Fox Chase Cancer Center. News-Medical.net highlighted the news.